Natixis Advisors L.P. Raises Stake in The Chemours Company (NYSE:CC)

Natixis Advisors L.P. increased its stake in shares of The Chemours Company (NYSE:CCFree Report) by 4.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 239,679 shares of the specialty chemicals company’s stock after buying an additional 10,513 shares during the period. Natixis Advisors L.P.’s holdings in Chemours were worth $7,559,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Deutsche Bank AG lifted its holdings in Chemours by 4,407.9% during the 3rd quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company’s stock worth $49,352,000 after purchasing an additional 1,720,389 shares in the last quarter. Anchor Investment Management LLC purchased a new stake in Chemours during the 4th quarter worth about $56,000. Assenagon Asset Management S.A. purchased a new stake in Chemours during the 4th quarter worth about $4,711,000. American Century Companies Inc. lifted its holdings in Chemours by 0.7% during the 3rd quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company’s stock worth $40,938,000 after purchasing an additional 10,075 shares in the last quarter. Finally, Sherbrooke Park Advisers LLC purchased a new stake in Chemours during the 3rd quarter worth about $1,044,000. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Chemours Stock Performance

Shares of NYSE CC opened at $28.43 on Friday. The stock has a market cap of $4.23 billion, a price-to-earnings ratio of -13.10 and a beta of 1.99. The company has a current ratio of 1.61, a quick ratio of 0.99 and a debt-to-equity ratio of 5.26. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $39.05. The stock’s 50-day moving average is $26.57 and its 200 day moving average is $27.89.

Chemours (NYSE:CCGet Free Report) last announced its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.07. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.35 billion. Chemours had a positive return on equity of 46.67% and a negative net margin of 5.51%. Chemours’s revenue for the quarter was down 12.1% compared to the same quarter last year. During the same period last year, the firm posted $0.98 EPS. On average, sell-side analysts anticipate that The Chemours Company will post 2.16 EPS for the current fiscal year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.00 annualized dividend and a yield of 3.52%. Chemours’s payout ratio is -46.08%.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and raised their price target for the company from $19.00 to $34.00 in a report on Tuesday, April 9th. Barclays lowered their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Finally, UBS Group raised their price target on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a report on Tuesday, April 2nd. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $31.63.

Check Out Our Latest Analysis on CC

Chemours Company Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.